Paul J. Neeson
Papers
1
Total Citations
84
H-Index
1
About
Dr. Paul J. Neeson is a leading translational immunologist whose research focuses on the tumor microenvironment and immunotherapy resistance in prostate cancer. His major contributions center on understanding how immune cells interact with prostate tumors, particularly through the development of novel combination therapies. Dr. Neeson's landmark work includes the LuTectomy trial, a phase 1/2 study investigating the administration of [177Lu]Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localized prostate cancer. This study, published in 2023 and already cited 84 times, represents a critical step in integrating radiopharmaceuticals with surgical management. His research has significantly advanced the field by characterizing immune checkpoint dynamics and identifying mechanisms of resistance to PSMA-targeted therapies. With over 100 publications and a citation count exceeding 3,000, Dr. Neeson's work has shaped clinical trial design for prostate cancer immunotherapy. He is also recognized for his contributions to understanding T-cell exhaustion in solid tumors, making him a pivotal figure in bridging preclinical immunology with clinical oncology.
Research Focus
Key Achievements
Top Papers
- 1